San Diego-based Tioga Pharmaceuticals said today that it has raised $18M in a new equity funding. The funding came from Forward Ventures, New Leaf Venture Partners, BB Biotech Ventures, and Genesys Capital Partners. According to Tioga, the new funding will go to fund a Phase 3 trial of its compound for treating irritable bowel syndrome. Tioga said it is expecting to kick off trials at 120 sites in the Untied States next month. More information »